(Q34098953)

English

Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

endocannabinoids

0 references

0 references

0 references

0 references

cannabinoid receptor

0 references

author name string

P H Reggio

1

1 reference

Europe PubMed Central

31 July 2017

H Traore

2

1 reference

Europe PubMed Central

31 July 2017

publication date

1 November 2000

1 reference

Europe PubMed Central

31 July 2017

Chemistry and Physics of Lipids

1 reference

Europe PubMed Central

31 July 2017

108

1 reference

Europe PubMed Central

31 July 2017

15-35

1 reference

Europe PubMed Central

31 July 2017

1-2

1 reference

Europe PubMed Central

31 July 2017

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Pharmacological and behavioral evaluation of alkylated anandamide analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide transport inhibition by the vanilloid agonist olvanil.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Lipid mimetics: the design and properties of conformationally-restricted arachidonic acid lipidic and peptidic analogues.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Cerebrodiene, arachidonyl-ethanolamide, and hybrid structures: potential for interaction with brain cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Chemical characterization of a family of brain lipids that induce sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Interactions between synthetic vanilloids and the endogenous cannabinoid system

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Molecular characterization of human and mouse fatty acid amide hydrolases

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide hydrolysis by human cells in culture and brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Anandamide may mediate sleep induction

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Unique Analogues of Anandamide: Arachidonyl Ethers and Carbamates and Norarachidonyl Carbamates and Ureas

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

On the conformational, physical properties and functions of polyunsaturated acyl chains

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Conformational analysis of arachidonic and related fatty acids using molecular dynamics simulations

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2). A putative L-shaped binding conformation utilizing the top channel region

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Potent Anandamide Analogs: The Effect of Changing the Length and Branching of the End Pentyl Chain

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Derivation of a pharmacophore model for anandamide using constrained conformational searching and comparative molecular field analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

The REM sleep-inducing action of a naturally occurring organic bromine compound in the encéphale isolé cat

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900185-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-3084(00)00185-7

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34098953&oldid=1539734208"